摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-chloro-2-(4-nitrophenyl)imidazo[1,2-a]pyridine | 304884-50-2

中文名称
——
中文别名
——
英文名称
8-chloro-2-(4-nitrophenyl)imidazo[1,2-a]pyridine
英文别名
——
8-chloro-2-(4-nitrophenyl)imidazo[1,2-a]pyridine化学式
CAS
304884-50-2
化学式
C13H8ClN3O2
mdl
——
分子量
273.678
InChiKey
BYOVBJYECYDFSF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    63.1
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    8-chloro-2-(4-nitrophenyl)imidazo[1,2-a]pyridine铁粉氯化铵 作用下, 以 乙醇 为溶剂, 反应 1.0h, 生成 4-{8-Chloroimidazo[1,2-a]pyridin-2-yl}aniline
    参考文献:
    名称:
    Discovery of novel N-(5-(tert-butyl)isoxazol-3-yl)-N′-phenylurea analogs as potent FLT3 inhibitors and evaluation of their activity against acute myeloid leukemia in vitro and in vivo
    摘要:
    FLT3 inhibitors have been explored as a viable therapy for acute myeloid leukemia (AML). However, the clinical outcomes of these FLT3 inhibitors were underwhelming except AC220. Therefore, the development of novel FLT3 inhibitors with high potency against both FLT3-WT and FLT3-ITD mutants are strongly demanded at the present time. In this study, we designed and synthesized a series of novel N-(5-(tert-butyl) isoxazol-3-yl)-N'-phenylurea derivatives as FLT3 inhibitors. SAR studies focused on the fused rings led to the discovery of a series of compounds with high potency against FLT3-ITD-bearing MV4-11 cells and significantly inhibitory activity toward FLT3. Among these compounds, N-(5-(tert-butyl) isoxazol-3-yl)-N'-(4-(7-methoxyimidazo[1,2-a]pyridin-2-yl)phenyl) urea (16i), displayed acceptable aqueous solubility, desirable pharmacokinetic profile and high cytotoxicity selectivity against MV4-11 cells. This compound can inhibit phosphorylation of FLT3 and induce apoptosis in a concentration-dependent manner. Further in vivo antitumor studies showed that 16i led to complete tumor regression in the MV4-11 xenograft model at a dose of 60 mg/kg/d while without observable body weight loss. This study had provided us a new chemotype of FLT3 inhibitors as novel therapic candidates for AML. (C) 2015 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmc.2015.06.033
  • 作为产物:
    描述:
    3-氯吡啶1-(4-nitrophenyl)-N-(1,2,4-triazol-4-yl)ethaniminecopper(l) iodide氧气 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 110.0 ℃ 、101.33 kPa 条件下, 反应 36.0h, 以44%的产率得到8-chloro-2-(4-nitrophenyl)imidazo[1,2-a]pyridine
    参考文献:
    名称:
    铜催化的好氧氧化C ?H取代吡啶的功能化:咪唑并吡啶衍生物的合成
    摘要:
    一种新型的,有效的,实用的方法为咪唑并吡啶衍生物的合成已经通过铜催化氧化有氧下显影 ħ取代吡啶与官能化ñ - (亚烷基)-4- ħ -1,2,4-三唑-4-胺。该程序通过N的切割发生 N键在Ñ(亚烷基)-4 - ħ -1,2,4-三唑-4-胺和活化的芳基C的在取代的吡啶H键。这是通过使用吡啶作为由过渡金属催化的C中的基板咪唑并吡啶衍生物的制备的第一个例子H功能化。该方法应为合成其他氮杂环化合物提供新颖有效的策略。
    DOI:
    10.1002/chem.201302737
点击查看最新优质反应信息